Is the atherogenic index of plasma a predictor for mortality in ischemic stroke patients?: a retrospective cross-sectional study
Keywords:
Ischemic stroke, Atherosclerosis, Cholesterol, Triglycerides, Mortality, Cardiovascular diseasesAbstract
BACKGROUND: The atherogenic index of plasma (AIP), derived from the logarithmic transformation of the triglyceride to high-density lipoprotein cholesterol ratio, is frequently used to predict cardiovascular events.
OBJECTIVE: This study aimed to investigate the association between AIP and 1-month mortality in patients with acute ischemic stroke (AIS).
DESIGN AND SETTING: Retrospective study was conducted in Türkiye.
METHODS: In total, 530 AIS patients were enrolled in this study. Clinical, demographic, and laboratory characteristics were recorded within 24 hours of admission. One-month mortality outcomes were analyzed in relation to the AIP of the patients.
RESULTS: Of the 530 patients, 140 patients did not survive during the follow-up period. The mean AIP was 0.50 ± 0.33 in survivors and 0.11 ± 0.27 in the mortality group (P = 0.001). In the receiver operating characteristic analysis, the AIP value of 0.291 had a sensitivity of 74.4%, specificity of 76.4%, positive predictive value of 75.92%, and negative predictive value of 74.9% for mortality. The AIP value above 0.291 had an AUC (area under curve) of 0.829 (95% CI [confidence interval] 0.78–0.88, P = 0.0001). In Cox regression analysis, AIP values below 0.291 (HR 3.962; 95% CI 2.643–5.937) were identified as an independent predictor of mortality. Higher mortality rates were observed in patients with cryptogenic stroke and AIP below 0.291 after stratification by stroke TOAST (P = 0.003).
CONCLUSIONS: Lower AIP is an independent predictor of short-term mortality in AIS patients, surpassing the sensitivity of traditional lipid parameters. This study provides a valuable prognostic tool for clinicians, offering a non-invasive and cost-effective test for a condition associated with substantial mortality and morbidity.
Downloads
References
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9. Erratum in: Lancet. 202014;396(10262):1562. PMID: 33069326; https://doi.org/10.1016/S0140-6736(20)32226-1.
Montellano FA, Ungethüm K, Ramiro L, et al. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke. 2021;52(2):543–51. https://doi.org/10.1161/STROKEAHA.120.029232. Erratum in: Stroke. 2021 Mar;52(3):e106. PMID: 33430636; https://doi.org/10.1161/STR.0000000000000369.
Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21(20):7609. PMID: 33076218; https://doi.org/10.3390/ijms21207609.
Nasr N, Ruidavets JB, Farghali A, et al. Lipoprotein (a) and carotid atherosclerosis in young patients with stroke. Stroke. 2011;42(12):3616–8. PMID: 21940953; https://doi.org/10.1161/STROKEAHA.111.624684.
Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017;120(3):502–13. PMID: 28154100; https://doi.org/10.1161/CIRCRESAHA.116.308441.
Santos HO, Earnest CP, Tinsley GM, Izidoro LFM, Macedo RCO. Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies. Prog Cardiovasc Dis. 2020;63(4):503–9. PMID: 32353373; https://doi.org/10.1016/j.pcad.2020.04.009.
Salazar MR, Carbajal HA, Espeche WG, et al. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med. 2013;273(6):595–601. PMID: 23331522; https://doi.org/10.1111/joim.12036.
Chang TI, Streja E, Soohoo M, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591–602. PMID: 28193609; https://doi.org/10.2215/CJN.08730816.
Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197. PMID: 30134981; https://doi.org/10.1186/s12944-018-0828-z.
Garg R, Knox N, Prasad S, Zinzuwadia S, Rech MA. The atherogenic index of plasma is independently associated with symptomatic carotid artery stenosis. J Stroke Cerebrovasc Dis. 2020;29(12):105351. PMID: 33045624; https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105351.
Liu T, Liu J, Wu Z, Lv Y, Li W. Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography. Clin Cardiol. 2021;44(4):518–25. PMID: 33751593; https://doi.org/10.1002/clc.23565.
Won KB, Heo R, Park HB, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors. Atherosclerosis. 2021;324:46–51. PMID: 33813155; https://doi.org/10.1016/j.atherosclerosis.2021.03.009.
Yu S, Yan L, Yan J, et al. The predictive value of nontraditional lipid parameters for intracranial and extracranial atherosclerotic stenosis: a hospital-based observational study in China. Lipids Health Dis. 2023;22(1):16. https://doi.org/10.1186/s12944-022-01761-4. Erratum in: Lipids Health Dis. 2024;23(1):260. PMID: 36709301; https://doi.org/10.1186/s12944-024-02250-6.
Wang C, Du Z, Ye N, et al. Using the atherogenic index of plasma to estimate the prevalence of ischemic stroke within a general population in a rural area of China. Biomed Res Int. 2020;2020:7197054. PMID: 33490253; https://doi.org/10.1155/2020/7197054.
Wang X, Zhao Y, Ji X, et al. Kongcun Town asymptomatic intracranial artery stenosis study in Shandong, China: cohort profile. BMJ Open. 2020;10(7):e036454. PMID: 32665348; https://doi.org/10.1136/bmjopen-2019-036454.
Deng QW, Li S, Wang H, et al. The short-term prognostic value of the triglyceride-to-high-density lipoprotein cholesterol ratio in acute ischemic stroke. Aging Dis. 2018;9:498–506.
Liu H, Liu K, Zhang K, et al. Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study. Ther Adv Neurol Disord. 2023;16:17562864221147743. PMID: 36710721; https://doi.org/10.1177/17562864221147743.
Liu H, Liu K, Pei L, et al. The atherogenic index of plasma predicts outcomes in acute ischemic stroke. Front Neurol. 2021;12:741–54.
Weir CJ, Sattar N, Walters MR, Lees KR. Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke. Cerebrovasc Dis. 2003;16(1):76–82. PMID: 12766366; https://doi.org/10.1159/000070119.
Çoban EK. Can TG/HDL ratio be an accurate predictor in the determination of the risk of cerebrovascular events in youngsters? Sisli Etfal Hastan Tıp Bul. 2018;52(3):201–5. PMID: 32595399; https://doi.org/10.14744/SEMB.2018.83097.
Serhat Tokgoz O, Guney F, Kaya A, et al. Acute-phase stroke outcome and lipids. Sisli Etfal Hastan Tıp Bul. 2021;55(4):538–44. PMID: 35317377; https://doi.org/10.14744/SEMB.2020.26817.
Sujatha R, Kavitha S. Atherogenic indices in stroke patients: a retrospective study. Iran J Neurol. 2017;16(2):78–82. PMID: 28761629.
Xu F, Zhong X. The association between atherogenic index of plasma and stroke in Chinese middle-aged and elderly population: a national cross-sectional study. Neurol Asia. 2023;28(4).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 São Paulo Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
